Table 3.
Clinical Features and Outcomes After the First Wave of the COVID-19 Pandemic
| Pre-C Group (n=19) | C-Group (n=15) | P value | |
|---|---|---|---|
| COVID-19 status at the end of FU | .1872 | ||
| Negative | 19 (100%) | 13 (87%) | |
| Positive | 0 | 2 (13%) | |
| COVID-19 swab performed until the end of FU | .1392 | ||
| Yes | 3 (15.8%) | 6 (33.3%) | |
| No | 16 (84.2%) | 9 (66.7%) | |
| COVID-19 swab performed preoperatively | .0294 | ||
| Yes | 0 | 4 (26.7%) | |
| No | 19 (100%) | 11 (73.3%) | |
| Confirmed COVID-19 infection | .1872 | ||
| Yes | 0 | 2 (13.3%) | |
| No | 19 (100%) | 13 (86.7%) | |
| Stay on ICU due to COVID-19 | 0 | 0 | 1.000 |
| Voluntarily underwent home quarantine | |||
| Yes | 13 (68.4%) | 12 (80.0%) | .6974 |
| No | 6 (31.6%) | 1 (6.7%) | .1039 |
| Ordered quarantine | 0 | 2 (13.3%) | .1872 |
| Proven contact with a COVID-19 infected person | |||
| Yes | 0 | 0 | 1.000 |
| No | 19 (100%) | 15 (100%) | 1.000 |
Data are n (%). P values are estimated 2-tailed Fisher exact test for categorical data.